Dianthus Therapeutics, Inc. Common Stock (DNTH) is a publicly traded Healthcare sector company. As of July 14, 2026, DNTH trades at $102.38 with a market cap of $5.34B and a P/E ratio of -23.07. DNTH moved +1.12% today. Year to date, DNTH is +140.82%; over the trailing twelve months it is +391.73%. Its 52-week range spans $13.37 to $102.33. Analyst consensus is strong buy with an average price target of $135.29. Rallies surfaces DNTH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks DNTH insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $102.38 |
| Market Cap | $5.34B |
| P/E Ratio | -23.07 |
| EPS | $-4.20 |
| Dividend Yield | 0.00% |
| 52-Week High | $102.33 |
| 52-Week Low | $13.37 |
| Volume | 432.67K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.04M |
| Net Income | $-162.34M |
| Gross Margin | 0.00% |
11 analysts cover DNTH: 0 strong buy, 11 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $135.29.